Charles River Laboratories (CRL)
$32.44
0.16 (+0.50%)
| CAPS Rating |
|
|---|---|
| Open | $0.00 |
| Previous Close | $32.28 |
| Daily Range | $32.16 - $32.53 |
| 52-Week Range | $19.92 - $40.14 |
| Market Cap | $2.14B |
| P/E Ratio | 8.86 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 596,285 |
| Average Daily Volume | 883,000 |
CRL
VS S&P 500 (SPY)
How do you think CRL will perform vs the S&P 500?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
CRL Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
CRL News and Commentary
- UPDATE 1-Charles River posts lower Q3 profit, cuts 2009 EPS view – Reuters
- Taking the Drug Industry's Temperature – The Motley Fool
- WuXi: Making Money Both Ways – The Motley Fool
- Covance Advances – The Motley Fool
- 4-Star Stocks on the Upswing – The Motley Fool
- Nothing to CRO About – The Motley Fool
- 4-Star Stocks on the Upswing – The Motley Fool
- Buyout or Sellout? – The Motley Fool
- Today's 5-Star Movers – The Motley Fool
- WuXi and Covance Call It Quits – The Motley Fool
- Recession Schmession, This Industry Is On Fire – The Motley Fool
- 5 Health Care Companies Flying Below the Radar – The Motley Fool
- Consider This Before Buying – The Motley Fool
- 3 Stocks Hitting High Notes – The Motley Fool
- Today's 5-Star Movers – The Motley Fool
- Stocks Everyone Says to Buy Now – The Motley Fool
Related News and Articles
- How Do You Say 'Drug Development' in Mandarin? – The Motley Fool
- 3 Stocks Hitting High Notes – The Motley Fool
RSS Headlines
Fool UK
